Free Trial

Elevance Health (ELV) Stock Price, News & Analysis

Elevance Health logo
$308.86 +13.43 (+4.55%)
Closing price 08/15/2025 03:58 PM Eastern
Extended Trading
$309.80 +0.94 (+0.30%)
As of 08/15/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Elevance Health Stock (NYSE:ELV)

Key Stats

Today's Range
$304.10
$312.00
50-Day Range
$274.10
$395.76
52-Week Range
$273.71
$567.26
Volume
3.41 million shs
Average Volume
3.07 million shs
Market Capitalization
$69.55 billion
P/E Ratio
13.14
Dividend Yield
2.21%
Price Target
$413.81
Consensus Rating
Moderate Buy

Company Overview

Elevance Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
97th Percentile Overall Score

ELV MarketRank™: 

Elevance Health scored higher than 97% of companies evaluated by MarketBeat, and ranked 26th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Elevance Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 12 buy ratings, 6 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Elevance Health has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Elevance Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Elevance Health are expected to grow by 14.99% in the coming year, from $33.96 to $39.05 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Elevance Health is 13.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.79.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Elevance Health is 13.14, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.14.

  • Price to Earnings Growth Ratio

    Elevance Health has a PEG Ratio of 1.13. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Elevance Health has a P/B Ratio of 1.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Elevance Health's valuation and earnings.
  • Percentage of Shares Shorted

    1.26% of the float of Elevance Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elevance Health has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elevance Health has recently increased by 4.41%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Elevance Health pays a meaningful dividend of 2.21%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Elevance Health has been increasing its dividend for 14 years.

  • Dividend Coverage

    The dividend payout ratio of Elevance Health is 29.11%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Elevance Health will have a dividend payout ratio of 17.52% next year. This indicates that Elevance Health will be able to sustain or increase its dividend.

  • Read more about Elevance Health's dividend.
  • Percentage of Shares Shorted

    1.26% of the float of Elevance Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elevance Health has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elevance Health has recently increased by 4.41%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Elevance Health has a news sentiment score of 1.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 36 news articles for Elevance Health this week, compared to 44 articles on an average week.
  • Search Interest

    56 people have searched for ELV on MarketBeat in the last 30 days. This is an increase of 211% compared to the previous 30 days.
  • MarketBeat Follows

    Only 11 people have added Elevance Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Elevance Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,438,990.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.29% of the stock of Elevance Health is held by insiders.

  • Percentage Held by Institutions

    89.24% of the stock of Elevance Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Elevance Health's insider trading history.
Receive ELV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter.

ELV Stock News Headlines

BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Elevance Health (ELV) Receives a Hold from Robert W. Baird
3 Stocks That Could Double Before 2027
Elevance Health (ELV) Receives a Buy from Mizuho Securities
See More Headlines

ELV Stock Analysis - Frequently Asked Questions

Elevance Health's stock was trading at $368.90 at the beginning of 2025. Since then, ELV shares have decreased by 16.3% and is now trading at $308.86.

Elevance Health, Inc. (NYSE:ELV) issued its quarterly earnings data on Thursday, July, 17th. The company reported $8.84 EPS for the quarter, missing analysts' consensus estimates of $9.30 by $0.46. The firm's revenue was up 14.3% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Elevance Health: Beacon Health Options, Aspire Healthcare Corp, America’s 1st Choice, HealthSun Health Plans, Simply Healthcare Holdings, Amerigroup, 1-800 Contacts, and others.

Elevance Health's top institutional investors include Vanguard Group Inc. (10.15%), State Street Corp (4.69%), Sanders Capital LLC (2.59%) and Geode Capital Management LLC (2.26%). Insiders that own company stock include Gail Boudreaux, Gloria M Mccarthy, Felicia F Norwood, Charles Morgan Kendrick Jr, Robert L Dixon Jr, Ramiro G Peru and Ronald W Penczek.
View institutional ownership trends
.

Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elevance Health investors own include NVIDIA (NVDA), Chevron (CVX), Meta Platforms (META), Advanced Micro Devices (AMD), Bristol Myers Squibb (BMY), Netflix (NFLX) and JPMorgan Chase & Co. (JPM).

Company Calendar

Record date for 6/25 Dividend
6/10/2025
Ex-Dividend for 6/25 Dividend
6/10/2025
Dividend Payable
6/25/2025
Last Earnings
7/17/2025
Today
8/17/2025
Record date for 9/25 Dividend
9/10/2025
Ex-Dividend for 9/25 Dividend
9/10/2025
Dividend Payable
9/25/2025
Next Earnings (Estimated)
10/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Managed Health Care
Current Symbol
NYSE:ELV
CIK
1156039
Employees
104,200
Year Founded
2004

Price Target and Rating

High Price Target
$505.00
Low Price Target
$297.00
Potential Upside/Downside
+34.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
18 Analysts

Profitability

EPS (Trailing Twelve Months)
$23.50
Trailing P/E Ratio
13.14
Forward P/E Ratio
9.09
P/E Growth
1.13
Net Income
$5.98 billion
Net Margins
2.83%
Pretax Margin
3.74%
Return on Equity
17.59%
Return on Assets
6.36%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
1.44
Quick Ratio
1.44

Sales & Book Value

Annual Sales
$177.01 billion
Price / Sales
0.39
Cash Flow
$39.10 per share
Price / Cash Flow
7.90
Book Value
$194.74 per share
Price / Book
1.59

Miscellaneous

Outstanding Shares
225,180,000
Free Float
224,525,000
Market Cap
$69.55 billion
Optionable
Optionable
Beta
0.58

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:ELV) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners